Canandaigua National Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Canandaigua National Bank & Trust’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.58M	Sell	3,242 -364	-10%	-$150K	0.33%	81
2019 Q4	$1.35M	Sell	3,606 -127	-3%	-$42.7K	0.23%	112
2019 Q3	$1.04M	Sell	3,733 -135	-3%	-$39.9K	0.18%	132
2019 Q2	$1.21M	Sell	3,868 -10	-0.3%	-$3.33K	0.22%	114
2019 Q1	$1.59M	Sell	3,878 -59	-1%	-$24.3K	0.31%	95
2018 Q4	$1.47M	Sell	3,937 -313	-7%	-$115K	0.31%	90
2018 Q3	$1.72M	Sell	4,250 -73	-2%	-$27.8K	0.31%	93
2018 Q2	$1.49M	Sell	4,323 -137	-3%	-$42.8K	0.29%	99
2018 Q1	$1.54M	Buy	+4,460	New	+$1.55M	0.2%	128

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Canandaigua National Bank & Trust's REGN Position: Q1 2020 in Review

Canandaigua National Bank & Trust reduced its Regeneron Pharmaceuticals (REGN) stake by 10% in Q1 2020, selling an estimated $150K and leaving 3,242 shares worth $1.58M. The position accounts for 0.33% of the portfolio, ranked #81.

Canandaigua National Bank & Trust first reported a position in REGN in Q1 2018 and has held it in 9 quarters since. The position peaked at $1.72M in Q3 2018. 817 funds tracked by Wall St. Rank hold REGN as of Q1 2020.

Canandaigua National Bank & Trust held 3,242 shares of Regeneron Pharmaceuticals worth $1.58M as of Q1 2020.
Canandaigua National Bank & Trust sold 364 Regeneron Pharmaceuticals shares in Q1 2020, an estimated $150K.
Regeneron Pharmaceuticals made up 0.33% of Canandaigua National Bank & Trust's portfolio in Q1 2020, its #81 holding.
Canandaigua National Bank & Trust first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 9 quarters since.
Canandaigua National Bank & Trust's Regeneron Pharmaceuticals position peaked at $1.72M in Q3 2018.
817 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2020.

Based on Canandaigua National Bank & Trust's 13F filing for Q1 2020, filed 16 Apr 2020.